Karyopharm Therapeutics Inc  (KPTI) - NASDAQGS

  Revenue / EPS Summary *  
 
 Fiscal Quarter 2020
(Fiscal Year)
2019
(Fiscal Year)
2018
(Fiscal Year)
March      
   Revenue $18,138(t) $155,000 $10,000(t)
   EPS -0.78 (3/31/2020) -1.09 (3/31/2019) -0.78 (3/31/2018)
   Dividends N/A N/A N/A
June      
   Revenue   $9,493(t) $19,891(t)
   EPS   -0.71 (6/30/2019) -0.58 (6/30/2018)
   Dividends   N/A N/A
September      
   Revenue   $13,149(t) $239,000
   EPS   -0.66 (9/30/2019) -0.81 (9/30/2018)
   Dividends   N/A N/A
December  (FYE)      
   Revenue   $18,096(t) $206,000
   EPS   -0.76 (12/31/2019) -0.97 (12/31/2018)
   Dividends   N/A N/A
Totals      
   Revenue $18,138(t) $40,893(t) $30,336(t)
   EPS -0.78 -3.22 -3.14
   Dividends N/A N/A N/A
   Previous 3 Years
 
 
©2020, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.